Proinflammatory Dual Receptor T Cells in Chronic Graft-versus-Host Disease

被引:10
|
作者
Balakrishnan, Amritha [1 ]
Gloude, Nicholas [2 ]
Sasik, Roman [3 ]
Ball, Edward D. [4 ]
Morris, Gerald P. [1 ]
机构
[1] Univ Calif San Diego, Dept Pathol, 9500 Gilman Dr,MC 0612, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA
[3] Univ Calif San Diego, Ctr Computat Biol & Bioinformat, La Jolla, CA 92093 USA
[4] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
关键词
T cell; Chronic graft-versus-host disease; T cell receptor; TCR; FOLLICULAR HELPER-CELLS; NEGATIVE SELECTION; DE-NOVO; TRANSPLANTATION; EXPRESSION; CD4(+); TCR; REPERTOIRE; ANTIGENS; AUTOIMMUNITY;
D O I
10.1016/j.bbmt.2017.07.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Defective post-transplantation thymopoiesis is associated with chronic graft-versus-host disease (GVHD), a multiorgan pathology affecting up to 80% of patients after allogeneic hematopoietic stem cell transplantation (HSCT). Previous work demonstrated that the subset of T cells expressing 2 T cell receptors (TCRs) is predisposed to alloreactivity, driving selective and disproportionate activity in acute GVHD in both mouse models and HSCT patients. Here we investigate a potential role for this pathogenic T cell subset in chronic GVHD (cGVHD). HSCT patients with cGVHD demonstrated increased numbers of dual TCR cells in circulation. These dual receptor cells had an activated phenotype, indicating an active role in cGVHD. Notably, single-cell RNA sequencing identified the increased dual TCR cells in cGVHD as predominantly expressing Tbet, indicative of a proinflammatory phenotype. These results identify dual TCR cells as specific mediators of pathogenic inflammation underlying cGVHD and highlight Tbet-driven T cell function as a potential pathway for potential therapeutic targeting. (C) 2017 American Society for Blood and Marrow Transplantation.
引用
收藏
页码:1852 / 1860
页数:9
相关论文
共 50 条
  • [1] Dual Receptor T Cells Mediate Pathologic Alloreactivity in Patients with Acute Graft-Versus-Host Disease
    Morris, Gerald P.
    Uy, Geoffrey L.
    Donermeyer, David
    DiPersio, John F.
    Allen, Paul M.
    SCIENCE TRANSLATIONAL MEDICINE, 2013, 5 (188)
  • [2] B cells in chronic graft-versus-host disease
    McManigle, William
    Youssef, Ayman
    Sarantopoulos, Stefanie
    HUMAN IMMUNOLOGY, 2019, 80 (06) : 393 - 399
  • [3] Biomarkers for acute and chronic graft-versus-host disease in regulatory T cells
    Ukena, Sya N.
    Geffers, Robert
    Buchholz, Stefanie
    Stadler, Michael
    Franzke, Anke
    TRANSPLANT IMMUNOLOGY, 2012, 27 (04) : 179 - 183
  • [4] The pathophysiology of chronic graft-versus-host disease
    Kansu, E
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2004, 79 (03) : 209 - 215
  • [5] The pathophysiology of chronic graft-versus-host disease
    Emin Kansu
    International Journal of Hematology, 2004, 79 : 209 - 215
  • [6] Belumosudil for chronic graft-versus-host disease
    Taylor, Breanna
    Cohen, Jaimie
    Tejeda, Jennifer
    Wang, Trent Peng
    DRUGS OF TODAY, 2022, 58 (05) : 203 - 212
  • [7] Chronic graft-versus-host disease
    Cutler, C
    Antin, JH
    CURRENT OPINION IN ONCOLOGY, 2006, 18 (02) : 126 - 131
  • [8] Chronic graft-versus-host disease
    Horwitz, ME
    Sullivan, KM
    BLOOD REVIEWS, 2006, 20 (01) : 15 - 27
  • [9] Chronic graft-versus-host disease
    Lee, SJ
    Vogelsang, G
    Flowers, MED
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2003, 9 (04) : 215 - 233
  • [10] Long-Lasting Graft-Derived Donor T Cells Contribute to the pathogenesis of Chronic Graft-versus-Host Disease in Mice
    Kosugi-Kanaya, Mizuha
    Ueha, Satoshi
    Abe, Jun
    Shichino, Shigeyuki
    Shand, Francis H. W.
    Morikawa, Teppei
    Kurachi, Makoto
    Shono, Yusuke
    Sudo, Naoto
    Yamashita, Ai
    Suenaga, Fumiko
    Yokoyama, Akihiro
    Yong, Wang
    Imamura, Masahiro
    Teshima, Takanori
    Matsushima, Kouji
    FRONTIERS IN IMMUNOLOGY, 2017, 8